CLL has a dedicated State-of-the-Art Korean FDA, CDSCO WC, WHO-GMP approved manufacturing and R&D facility located in Punjab, India. Manufacturing capabilities and strategic expansion plans reformed CLL into one of the largest manufacturer of several APIs in the field of Cardiovascular, CNS, Diabetes and other segments.